Katalog der Deutschen Nationalbibliothek

Expertensuche ?

Servicezeiten in Frankfurt am Main ab 1. Dezember 2025: Montag bis Freitag 9–18 Uhr und Samstag 10–16 Uhr
Service hours in Frankfurt am Main from 1 December 2025: Monday to Friday 9:00-18:00 and Saturday 10:00-16:00

Leichte Bedienung, intuitive Suche: Die Betaversion unseres neuen Katalogs ist online! → Zur Betaversion des neuen DNB-Katalogs

24. Dezember 2025 bis 1. Januar 2026: Die Deutsche Nationalbibliothek bleibt an beiden Standorten geschlossen. Bestellte Medien werden am 2. Januar 2026 bereitgestellt. // 24 December 2025 to 1 January 2026: The German National Library will be closed at both locations. Ordered media will be made available on 2 January 2026.

Ergebnis der Suche nach: "Originator"
im Bestand: Gesamter Bestand

121 - 130 von 138

	121	Interchangeability and adverse events in originator-rituximab and its biosimilar (CT-P10) among rheumatic patients: a real-life experience Enthalten in Internal and emergency medicine Bd. 18, 24.2.2023, Nr. 3, date:4.2023: 791-799
	122	Kein Nachteil durch Wechsel zwischen Biosimilar und Originator Enthalten in Hautnah / Dermatologie Bd. 34, 12.5.2018, Nr. 3, date:5.2018: 28-29
	123	Label discrepancies between originator and generic drugs impact safety Enthalten in Reactions weekly Bd. 1802, 2.5.2020, Nr. 1, date:5.2020: 8
	124	Non-medical Switching from Originator Tumor Necrosis Factor Inhibitors to Their Biosimilars: Systematic Review of Randomized Controlled Trials and Real-World Studies Enthalten in Advances in therapy Bd. 35, 6.8.2018, Nr. 9, date:9.2018: 1295-1332
	125	Non-pharmacological Effects in Switching Medication: The Nocebo Effect in Switching from Originator to Biosimilar Agent Enthalten in BioDrugs Bd. 32, 29.9.2018, Nr. 5, date:10.2018: 397-404
	126	Originator-to-biosimilar non-medical switch may not yield such great cost savings Enthalten in PharmacoEconomics & outcomes news Bd. 892, 27.11.2021, Nr. 1, date:11.2021: 17
	127	Outcomes Following Adalimumab Bio-originator to Biosimilar Switch—A Comparison Using Real-world Patient- and Physician-Reported Data in European Countries Enthalten in Rheumatology and therapy Bd. 10, 12.1.2023, Nr. 2, date:4.2023: 433-445
	128	Perception of Originator Biologics and Biosimilars: A Survey Among Belgian Rheumatoid Arthritis Patients and Rheumatologists Enthalten in BioDrugs Bd. 31, 19.9.2017, Nr. 5, date:10.2017: 447-459
	129	Physicochemical and Functional Comparability Between the Proposed Biosimilar Rituximab GP2013 and Originator Rituximab Enthalten in BioDrugs Bd. 27, 7.5.2013, Nr. 5, date:10.2013: 495-507
	130	Rapid monitoring of health services use following a policy to switch patients from originator to biosimilar etanercept—a cohort study in British Columbia Enthalten in BMC Rheumatology Bd. 6, 27.1.2022, Nr. 1, date:12.2022: 1-9

121 - 130 von 138

Alle Materialarten

Alle Kataloge/Sammlungen

Alle Standorte > Leipzig (138)

Aktionen

Administration